Home › Markets › Health Care › UTMD

Utah Medical Products Inc. (UTMD)

UTMD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$74.71
+0.40% on the day
Market cap
$237.9M
Micro cap
Revenue · 2025
$38.5M
-5.8% on 2024
Net income · 2025
Net income not in SEC XBRL data
0.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerUTMD on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000706698
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inUT

Financials · 2025

LineValue
Revenue$38.5M
Net incomeNot in SEC XBRL data
Operating income$11.4M
Net margin0.0%
Operating margin29.6%
Revenue growth-5.8%
Cash$85.8M
Total assets$122.5M
P/E (computed)Net income was not positive
P/S (computed)6.2×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
UTAH MEDICAL FORM S-3 JUNE 12, 2012
S-32012-06-12
Latest annual report
UTAH MEDICAL PRODUCTS INC - FORM 10-K SEC FILING
10-K2026-03-27
Latest quarterly / interim
UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
10-Q2026-08-12
Latest current report
UTAH MEDICAL PRODUCTS, INC. - FORM 8-K SEC FILING
8-K2026-08-31
Latest proxy
PROXY STATEMENT
DEF 14A2026-04-02

Source: SEC EDGAR submissions feed, 844 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
PROFProfound Medical Corp.$7.01-3.31%$256.1M
OSUROraSure Technologies Inc.$3.81-2.81%$262.8M
TMCITreace Medical Concepts Inc.$4.100.00%$266.6M
INFUInfuSystems Holdings Inc.$13.49-0.81%$268.7M
ANIKAnika Therapeutics Inc.$20.53+0.29%$274.8M
PDEXPro-Dex Inc.$62.27-1.30%$201.3M
MOBIMobia Medical Inc.$8.50-1.16%$283.0M
CLPTClearPoint Neuro Inc.$9.81-3.82%$299.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier